Skip to content
    CRS
    Earnings call· Mar 2025(Q3 FY25)

    CARPENTER TECHNOLOGY Q3 FY25 earnings call CRS

    Apr 24, 2025 Source

    Executive summary

    Carpenter Technology Q3 FY25 — Record Operating Income and Raised FY25 Guidance

    Carpenter Technology delivered an exceptional quarter, achieving record operating income and expanding SAO segment margins, driven by strong market demand in Aerospace and Defense, and effective manufacturing execution. The company raised its full-year operating income guidance and remains confident in its long-term growth trajectory, supported by strategic capacity investments and a disciplined capital allocation approach. Management highlighted the strength of its specialized product portfolio and ability to navigate supply chain disruptions.

    Highlights

    5

    • Generated record operating income of $138 million, a 53% increase year-over-year.

    • SAO segment adjusted operating margin expanded to a record 29.1%, up from 21.4% a year ago.

    • Achieved $34 million in adjusted free cash flow, driven by strong earnings and working capital management.

    • Repurchased $37.5 million of shares in the quarter, contributing to $78 million year-to-date against a $400 million authorization.

    • Raised full fiscal year 2025 operating income guidance to $520 million to $527 million, representing a nearly 50% increase over FY24.

    Concerns

    1

    • Medical end-use market sales were down 14% year-over-year, though expected to rebound in Q4.

    Guidance & targets

    11
    CategoryTargetConfidence
    Full-year FY25 Operating Income
    $520 million to $527 million
    high materiality
    High
    Full-year FY25 Adjusted Free Cash Flow
    $250 million to $300 million
    high materiality
    High
    Q4 FY25 Operating Income Increase
    6% to 11%
    medium materiality
    High
    Full-year FY25 Capital Expenditures
    $155 million to $160 million
    medium materiality
    High
    SAO Segment Operating Income
    $160 million to $165 million
    high materiality
    High
    PEP Segment Operating Income
    $10 million to $12 million
    medium materiality
    High
    FY27 Operating Income
    $765 million to $800 million
    high materiality
    High
    FY25-FY27 Free Cash Flow Generation
    $1 billion
    high materiality
    High
    FY26 Operating Income
    materially higher
    medium materiality
    High
    Brownfield Investment Return on Capital
    greater than 20%
    medium materiality
    High
    Q4 FY25 Effective Tax Rate
    23%
    low materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    SAO
    Margin expansion driven by productivity, product mix optimization, and pricing actions. Achieved record operating income and adjusted operating margin.
    Adjusted operating margin prior quarter: 28.3%Adjusted operating margin year ago: 21.4%Operating income growth YoY: 46%Volume change YoY: -12%Volume change QoQ: similar
    		$519.4 million8%8%$151.4 million operating income, 29.1% adjusted operating margin
    PEP
    Improvement driven by the additive business with more normalized shipments. Dynamet is the major driver, with 95% of its sales to medical and aerospace.
    Operating income year ago: $9.2 millionOperating income prior quarter: $7 million
    		$96.8 million2%12%$10.9 million operating income

    Operational metrics

    21
    Total Case Incident Rate
    1.4
    Q3 FY25

    Reflects ongoing efforts in safety-first behaviors and training.

    Adjusted Operating Income
    $137.8 million53% higher YoY
    Q3 FY25

    Represents the best quarterly operating income result on record.

    Gross Profit
    $200.8 million37% higher YoY
    Q3 FY25

    Driven by increasing productivity, improved product mix, and higher prices.

    SG&A Expenses
    $63 million
    Q3 FY25

    Includes $24.4 million of corporate costs.

    Corporate Costs
    $24.4 million
    Q3 FY25

    Expected to be in line with this level for Q4 FY25.

    Effective Tax Rate
    21.8%slightly lower than anticipated
    Q3 FY25

    Expected to normalize to 23% in Q4 FY25.

    Cash from Operating Activities
    $74 million
    Q3 FY25

    Discretionary pension contributions were made to maintain funded ratios for one plan; no additional discretionary contributions planned.

    Capital Expenditures
    $40 million
    Q3 FY25

    Part of the planned $155 million to $160 million for FY25.

    Share Repurchases
    $37.5 million
    Q3 FY25

    Part of the authorized share repurchase program, complementing the quarterly dividend.

    Total Liquidity
    $500.4 million
    Q3 FY25 end

    Liquidity remains healthy with no near-term debt maturities.

    Leverage Ratio
    Under 1xhistoric lows
    Q3 FY25 end

    Reflects strong financial position.

    Aerospace and Defense Sales Growth
    12%sequentially
    Q3 FY25

    Driven by increased shipments and higher pricing.

    Engine Sales Growth
    16%sequentially
    Q3 FY25

    Driven by increased shipments to many customers combined with higher pricing.

    Fasteners Sales Growth
    25%sequentially
    Q3 FY25

    Reflects strong demand within the Aerospace and Defense market.

    Medical Sales Growth
    -14%YoY
    Q3 FY25

    Compared to a record prior year quarter, with underlying demand remaining positive and expected to rebound in Q4.

    Energy Sales Growth
    9%sequentially
    Q3 FY25

    With significant increases in sales to power generation customers.

    Energy Sales Growth
    26%YoY
    Q3 FY25

    With significant increases in sales to power generation customers.

    Order Intake Growth
    >20%sequentially
    Q3 FY25

    Described as a "really good order intake quarter."

    Aerospace Engine Lead Times
    Up to 60 weeksno change
    current

    Lead times are capped by the company's order book and are not expected to change significantly.

    Tariff Impact on Total Spend
    very low single digits
    current

    Deep analysis showed minimal impact, with nickel (largest input) being exempt from tariffs.

    Dynamet Sales Mix
    95%
    Q3 FY25

    Dynamet is the major driver of the PEP segment's profitability.

    Industry KPIs

    1
    MetricValueDetails
    Total company backlogwell over 2xmultiple

    Orderbook & backlog

    1
    Total company backlogwell over 2x pre-COVID levelsQ3 FY25

    not moving that much at the high end now

    capping order book makes it a less effective metric for market demand

    Deals & partnerships

    1
    Multiple customersLong-term supply agreements (LTAs)3-5 years

    Two LTAs recently concluded, with other LTA discussions expected to conclude over the coming quarter. These agreements are long-term, typically 3-5 years, and are not impacted by short-term market dynamics.

    Capital programs

    1
    Brownfield Expansion Projectunderway
    Period spend: $30 million
    Funding: internal cash generation

    Benefit: add high-purity primary and secondary melt capacity to feed existing downstream finishing assets

    This investment will not materially impact the industry's current supply and demand imbalance, but provides an earnings accelerator to the company's already attractive earnings growth projections. Expected to yield an attractive return on capital of greater than 20%. Equipment for this project is highly specialized, primarily from Europe, with associated tariffs expected but representing a small piece of the overall spend.

    Risks & headwinds

    3
    Tariff impact on raw material costsCurrent/Ongoing

    very low single digits of our total spend

    Mitigation: Expects to use established surcharge mechanisms to pass through 100% of incremental tariffs. Nickel, the largest input, is primarily from Canada and exempt.

    Supply chain disruptions and build rate changesPast few years and ongoing

    significant disruptions

    Mitigation: Company's strategic positioning, broad portfolio, and focus on manufacturing execution have enabled it to navigate challenges and achieve record financial results.

    Medical market destockingQ3 FY25, largely behind them

    Medical sales down 14% YoY in Q3 FY25

    Mitigation: Expects a "pretty sizable increase" in Medical sales in Q4 FY25, with underlying demand remaining positive.

    What to watch in Q4 FY25

    5

    Medical sales growth

    Q4 FY25
    CurrentDown 14% YoY in Q3 FY25
    Targetup quite a bit QoQ

    Why it matters

    Indicates recovery from destocking and continued underlying demand in a key end-use market.

    To maybe give you a little bit of relief or a little bit of comfort, as we look forward next quarter, to fourth quarter, I usually don't project sales by end-use market, but Medical, we project to be up quite a bit in the fourth quarter compared to Q3. So what we're hearing from customers, that any of that type of destocking, if you will, is largely behind us now. And our forecast supports that, and we see a big -- a pretty sizable increase in Q4.

    Q&A highlights

    8

    Characterize Q3 order trends and if emergency orders are increasing due to Boeing build rate momentum.

    Orders were up over 20% sequentially. Customers continue to push for earlier deliveries, which could be considered emergency orders.

    “Scott, without getting into any of the specific figures on orders, I can tell you that they were up just a bit over 20% sequentially. So a really good order intake quarter. Emergency orders, I can say that we still continue to have customers pushing to get their deliveries earlier than planned, whether that constitutes how you want to call it, emergency order or not, but we still have that quite frequently.”

    asked by Scott Deuschle · answered by Tony Thene

    2 min read7 chapters

    Detailed Narrative

    01

    Safety Performance

    Carpenter Technology reported a total case incident rate of 1.4 through the third quarter of fiscal year 2025. The company is actively promoting safety-first behaviors, hands-on scenario-based training, and reinvigorating daily safety routines to achieve its ultimate goal of a zero-injury workplace through consistent action and continuous improvement.

    02

    Market Dynamics and End-Use Performance

    Sales in the Aerospace and Defense end-use market increased 12% sequentially on 6% higher volumes, with engine sales up 16% and fasteners up 25% sequentially. The defense business remains strong, including emergency support for a specific platform for the Department of Defense. Medical sales were flat sequentially and down 14% year-over-year, attributed to potential destocking, but underlying demand is positive, with a sizable increase projected for Q4 FY25. Energy sales grew 9% sequentially and 26% year-over-year, driven by power generation customers.

    03

    Tariff Situation and Strategic Positioning

    The company anticipates limited impact from evolving tariffs, planning to use established surcharge mechanisms to pass through any incremental costs. Nickel, its largest raw material input, is primarily sourced from Canada and is currently exempt. Carpenter Technology's highly specialized products, unique capabilities, and significant qualifications mean few alternative sources exist, often only within the United States, providing a strong competitive advantage.

    04

    Long-Term Agreements (LTAs)

    Carpenter Technology concluded two long-term supply agreements (LTAs) in the quarter, which are expected to provide significant benefits. More LTA discussions are anticipated to conclude in the coming quarter. These agreements typically span 3-5 years and are driven by the long-term supply and demand imbalance in the industry, rather than short-term market disruption🌐s.

    05

    Brownfield Expansion Project

    The company's brownfield expansion project will add high-purity primary and secondary melt capacity, feeding existing downstream finishing assets. This investment is viewed as an earnings accelerator, funded through internal cash generation, and is expected to yield a return on capital greater than 20%. The specialized equipment for this project is primarily sourced from Europe, with associated tariffs expected but representing a small portion of the overall spend.

    06

    Inventory Management and Cash Flow

    Inventory levels, particularly work-in-progress (WIP), are expected to decrease in Q4 FY25. This reduction is a significant factor in the company's confidence in achieving its full fiscal year 2025 adjusted free cash flow target of $250 million to $300 million, demonstrating disciplined working capital management.

    07

    Backlog Commentary

    Management clarified that a theoretical 0.5% backlog decrease mentioned by an analyst was not representative of the company's actual backlog. The backlog remains 'well over 2x' pre-COVID levels, which were considered strong. The company's practice of capping its order book means that backlog figures are less effective as a real-time indicator of market demand, as it can fluctuate due to major OEMs not producing planes or customers pulling forward orders.

    AI-generated summary of the company’s earnings call. Not investment advice.